About Tasly pharmaceuticals Co. Ltd.Tasly pharmaceutical Co. Ltd., based in Tianjin, China, was founded in May 1994. Through its development, Tasly has become a high-tech group whose scope of businesses includes modern TCMs, chemical & biological drugs, healthcare products and functional foods. The Company has a large research institute and oversees its own product development, planting, manufacturing, commercial sales and distribution. Tasly manufactures and sells its traditional Chinese medicines, generic drugs, vaccines and personal care products in China and in several other countries around the world. Tasly entered a drug-wholesaling venture with the UK’s Co-operative Group in 2007. For more information about the Company, please visit www.tasly.com.About ICON plcICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has around 8,300 employees, operating from 79 locations in 38 countries.
Tasly Pharmaceuticals Selects ICON As It Seeks First FDA Approval Of A Traditional Chinese Medicine
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts